These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33117115)

  • 41. [
    Keeling GP; Sherin B; Kim J; San Juan B; Grus T; Eykyn TR; Rösch F; Smith GE; Blower PJ; Terry SYA; T M de Rosales R
    Bioconjug Chem; 2021 Jul; 32(7):1276-1289. PubMed ID: 32786371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI.
    Lamb J; Holland JP
    J Nucl Med; 2018 Mar; 59(3):382-389. PubMed ID: 29025988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New-generation radiotracers for nAChR and NET.
    Ding YS; Fowler J
    Nucl Med Biol; 2005 Oct; 32(7):707-18. PubMed ID: 16243646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiopharmaceuticals in neurological and psychiatric disorders.
    Valotassiou V; Wozniak G; Sifakis N; Demakopoulos N; Georgoulias P
    Curr Clin Pharmacol; 2008 May; 3(2):99-107. PubMed ID: 18690884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
    Sadeghzadeh M; Wenzel B; Gündel D; Deuther-Conrad W; Toussaint M; Moldovan RP; Fischer S; Ludwig FA; Teodoro R; Jonnalagadda S; Jonnalagadda SK; Schüürmann G; Mereddy VR; Drewes LR; Brust P
    Molecules; 2020 May; 25(10):. PubMed ID: 32423056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An in vitro assay for predicting successful imaging radiotracers.
    Patel S; Hamill T; Hostetler E; Burns HD; Gibson RE
    Mol Imaging Biol; 2003; 5(2):65-71. PubMed ID: 14499146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders.
    Lopresti BJ; Royse SK; Mathis CA; Tollefson SA; Narendran R
    J Neurochem; 2023 Feb; 164(3):364-400. PubMed ID: 35536762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac PET for translational imaging.
    Rischpler C; Paschali A; Anagnostopoulos C; Nekolla SG
    Curr Cardiol Rep; 2015 May; 17(5):28. PubMed ID: 25894794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular and Molecular Imaging with SPECT and PET in Brain Tumors.
    Sadaghiani MS; Sheikhbahaei S; Rowe SP; Pomper MG; Solnes LB
    Radiol Clin North Am; 2021 May; 59(3):363-375. PubMed ID: 33926683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoamine oxidase: radiotracer chemistry and human studies.
    Fowler JS; Logan J; Shumay E; Alia-Klein N; Wang GJ; Volkow ND
    J Labelled Comp Radiopharm; 2015 Mar; 58(3):51-64. PubMed ID: 25678277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preclinical imaging: an essential ally in modern biosciences.
    Cunha L; Horvath I; Ferreira S; Lemos J; Costa P; Vieira D; Veres DS; Szigeti K; Summavielle T; Máthé D; Metello LF
    Mol Diagn Ther; 2014 Apr; 18(2):153-73. PubMed ID: 24146172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET radiopharmaceuticals for probing enzymes in the brain.
    Holland JP; Cumming P; Vasdev N
    Am J Nucl Med Mol Imaging; 2013; 3(3):194-216. PubMed ID: 23638333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT.
    Werner RA; Thackeray JT; Pomper MG; Bengel FM; Gorin MA; Derlin T; Rowe SP
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31331016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical in vivo cancer, straightway to patients?
    de Jong M; Mather S; Maina T
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):145-152. PubMed ID: 28347131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
    Kong FL; Kim EE; Yang DJ
    Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging.
    Stendahl JC; Kwan JM; Pucar D; Sadeghi MM
    J Nucl Med; 2022 May; 63(5):649-658. PubMed ID: 35487563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-resolution and high-sensitivity PET for quantitative molecular imaging of the monoaminergic nuclei: A GATE simulation study.
    Wang Z; Cao X; LaBella A; Zeng X; Biegon A; Franceschi D; Petersen E; Clayton N; Ulaner GA; Zhao W; Goldan AH
    Med Phys; 2022 Jul; 49(7):4430-4444. PubMed ID: 35390182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deconvolution of Plasma Pharmacokinetics from Dynamic Heart Imaging Data Obtained by Single Positron Emission Computed Tomography/Computed Tomography Imaging.
    Wang Z; Wang L; Ebbini M; Curran GL; Min PH; Siegel RA; Lowe VJ; Kandimalla KK
    J Pharmacol Exp Ther; 2023 Jul; 386(1):102-110. PubMed ID: 37221092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors.
    Moran MD; Wilson AA; Elmore CS; Parkes J; Ng A; Sadovski O; Graff A; Daskalakis ZJ; Houle S; Chapdelaine MJ; Vasdev N
    Bioorg Med Chem; 2012 Jul; 20(14):4482-8. PubMed ID: 22717238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.